ArticleJPRAS open2021
Management of secondary embolization that arose after intraarterial thrombolytic treatment of cosmetic facial filler-induced arterial occlusion.
Article in JPRAS open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.
- Nonsurgical Rhinoplasty: An Updated Systematic Review of Technique, Outcomes, Complications, and Its Treatments.Aesthetic plastic surgery · 2024Pooled it
- Ophthalmological Complications of Aesthetic Medicine Procedures: A Narrative Review.Journal of clinical medicine · 2025Review
- Clinical Manifestations and Prognosis of Embolism Caused by Filler Injection in Different Facial Regions.Plastic and reconstructive surgery. Global open · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Facial injections with cosmetic fillers can lead to local artery occlusion. The bilateral nasolabial folds of a 39-year-old woman were injected with hyaluronic acid at another hospital. After the righthand injection, the patient immediately felt pain that ran from the right nasolabial fold to the nasal alar. The injecting doctor suspected embolism due to intravascular misinjection and immediately injected hyaluronidase and vasodilator subcutaneously and intravenously, respectively. Five days later, the patient presented at our hospital with extensive endovascular embolization-related signs: along with some oral mucosa, the skin of the right nasolabial fold, right nasal alar, and right mouth corner exhibited necrosis. We diagnosed secondary peripheral embolus, and we used the treatment, namely, subcutaneously flooding/immersing the embolization site in the peripheral blood vessels with 2000 units of hyaluronidase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.